Youper Review 2026 (Historical): The Stanford-Studied AI Chatbot That Shut Down

What Happened to Youper

Youper discontinued its services on September 30, 2026. The company announced the shutdown on its own website: an archived copy of youper.ai, August 7, 2026 shows a site-wide banner reading "Youper is shutting down September 30, 2026 — export your data". youper.ai has since gone offline.

Independent coverage reports the same date: ChoosingTherapy's Youper review carries an update dated August 2026 stating that "the app will stop working on September 30, 2026", and Psychology.com's Youper page states that "Youper shut down on September 30, 2026." There is no successor product. Because Youper can no longer be used, it carries no editorial score and is no longer ranked in our consumer AI therapy app rankings.

Quick Verdict (Historical)

Youper occupied an interesting middle ground in the AI therapy app market. It was more clinically focused than Replika (which is an AI companion, not a therapy tool), more multi-modal in therapy approaches than Woebot was, but less clinically validated than Wysa (30+ papers vs Youper's single Stanford study).

Its core strength was the integration of validated clinical assessments (GAD-7 for anxiety, PHQ-9 for depression) directly into the AI chatbot experience, so users tracked their symptom progression with instruments that clinicians actually use. Its core limitations were annual-only billing and the fact that several of its most useful features (meditation, sleep, more comprehensive crisis support) sat behind the Premium paywall.

Clinical Evidence (Historical)

Youper's clinical validation came from a Stanford University observational study published in JMIR. The study remains part of the published evidence base on AI mental health chatbots, even though the product it evaluated no longer exists:

• Sample size: 4,517 participants
• Results: Significant symptom reduction for anxiety (effect size d=0.57) and depression (effect size d=0.46) within 2 weeks
• Retention: 42.66% retention at 4 weeks — above average for mental health apps
• Limitation: Observational study with no randomized control group — weaker evidence than an RCT

The effect sizes (0.57 for anxiety, 0.46 for depression) represent medium effects — clinically meaningful but not dramatic. For context, Wysa's RCTs show similar effect sizes for anxiety but with stronger methodology (randomized controls). Youper had not published an RCT, which limited the strength of its clinical claims compared to Wysa.

What Youper Offered

• AI conversational chatbot (Emotional Health Assistant)
• Evidence-based CBT, ACT, DBT, PST, Mindfulness interventions
• Mood tracking and daily check-ins
• Clinically validated assessments (GAD-7, PHQ-9)
• Thought journaling and cognitive restructuring
• Personalized mental health insights

The AI chatbot (marketed as an "Emotional Health Assistant") used natural language processing to engage users in structured therapeutic conversations. It drew from five evidence-based modalities: CBT (thought challenging, behavioral activation), ACT (values clarification, cognitive defusion), DBT (distress tolerance, emotion regulation), PST (problem-solving therapy), and mindfulness (guided meditation, breathing exercises). It had a limited free tier and an annual-only Premium subscription.

The integrated GAD-7 and PHQ-9 assessments were a meaningful clinical feature. These are the same validated instruments that psychiatrists and therapists use to screen for generalized anxiety disorder and major depressive disorder. Youper administered them periodically and tracked scores over time, providing a longitudinal view of symptom progression.

Thought journaling and cognitive restructuring exercises — core CBT techniques — were central to the app. The AI guided users through identifying distorted thinking patterns, challenging negative thoughts, and developing balanced alternatives.

Therapy Modalities

Youper covered a broader range of therapy approaches than most AI competitors:

• Cognitive Behavioral Therapy (CBT): Thought records, cognitive restructuring, behavioral activation, exposure hierarchies
• Acceptance and Commitment Therapy (ACT): Values clarification, cognitive defusion, committed action planning
• Dialectical Behavior Therapy (DBT): Distress tolerance skills, emotion regulation techniques
• Problem-Solving Therapy (PST): Structured problem identification and solution generation
• Mindfulness: Guided meditation, breathing exercises, body awareness

The multi-modality approach was a genuine advantage. Different therapeutic approaches work better for different people and different conditions. CBT is most effective for specific anxiety disorders and depression; ACT works well for chronic pain and acceptance-based challenges; DBT excels for emotion dysregulation. Having all five in one app let users find what worked best for them.

Weaknesses and Limitations (Historical)

• No monthly subscription: Annual-only billing with no monthly option forced a commitment before adequate evaluation
• New version complaints: Long-time users reported that app updates removed or limited previously available features
• Crisis support behind paywall: Basic crisis resources were available, but more comprehensive crisis support features required Premium
• No human support option: Unlike Wysa (coaching add-on), Youper was AI-only with no path to human professional support
• No RCT: The Stanford study was observational, not a randomized controlled trial — weaker evidence than Wysa's published RCTs

What Former Youper Users Can Use Instead

• For an evidence-based CBT chatbot → Wysa. The closest like-for-like replacement: an AI chatbot delivering CBT, DBT, ACT and mindfulness-based exercises, with 30+ peer-reviewed publications including RCTs, NHS endorsement, CE-mark status as a Class I medical device in the EU, and optional coaching with licensed professionals. Wysa review
• For symptom tracking → MindDoc. If Youper's GAD-7/PHQ-9 check-ins were what you relied on, MindDoc takes a measurement-first approach: structured mood tracking, validated self-assessments and CBT-based courses, with less chatbot conversation. MindDoc review
• For anything beyond mild-to-moderate symptoms → a licensed clinician. No app replaces professional care. If you are in crisis, call 988 or text HOME to 741741 in the US, or contact local emergency services.

For how the two chatbots compared while both were available, see our historical Wysa vs Youper comparison; for the full field of apps you can still use, see our consumer AI therapy app rankings.

Bottom Line

Youper was a well-designed AI emotional health assistant with unusually broad therapy modality coverage (CBT, ACT, DBT, PST, mindfulness), integrated GAD-7 and PHQ-9 assessments, and a Stanford observational study behind it. Annual-only billing, no human support escalation and the absence of an RCT were its real limitations.

Youper discontinued its services on September 30, 2026, so it is no longer an option. For most former users, Wysa is the closest evidence-backed substitute available today; MindDoc is the better fit if symptom tracking mattered most.

Frequently Asked Questions

Is Youper still available?

No. Youper discontinued its services on September 30, 2026. Before the shutdown, Youper's own website carried a banner announcing that it was shutting down on that date, and youper.ai has since gone offline. There is no successor product.

What should former Youper users use instead?

Wysa is the closest replacement: an AI chatbot delivering CBT, DBT, ACT and mindfulness-based exercises, with 30+ peer-reviewed publications including RCTs, NHS endorsement and optional coaching with licensed professionals. MindDoc suits users who mainly valued Youper's symptom tracking: it combines structured mood tracking with validated self-assessments and CBT-based courses. Neither replaces a licensed clinician. Anyone in crisis should call 988 or text HOME to 741741.

Was there clinical evidence that Youper worked?

Some, though limited. A longitudinal observational study by Mehta and colleagues at Stanford, published in JMIR (2021), examined 4,517 paying Youper users and found medium-effect-size symptom reductions for anxiety (Cohen's d=0.57) and depression (d=0.46) within two weeks. The study was observational with no randomized control group, which is weaker evidence than a randomized controlled trial.

What therapy modalities did Youper use?

Youper drew from five evidence-based therapy approaches: Cognitive Behavioral Therapy (CBT), Acceptance and Commitment Therapy (ACT), Dialectical Behavior Therapy (DBT), Problem-Solving Therapy (PST), and mindfulness. It also administered clinically validated assessments — GAD-7 for anxiety and PHQ-9 for depression — and tracked scores over time.

How did Youper compare to Wysa?

Wysa had stronger clinical validation (30+ peer-reviewed papers including RCTs versus Youper's single observational study) and offered optional human coaching. Youper covered a broader set of therapy modalities and built GAD-7 and PHQ-9 assessments into its chatbot. Wysa remains available; Youper shut down on September 30, 2026.